Int J Cancer. 2017 Jul 15;141(2):364-376. doi: 10.1002/ijc.30730. Epub 2017 May 9.

Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5.

Ke Y1, Bao T1,2, Zhou Q3, Wang Y4, Ge J1, Fu B1, Wu X5, Tang H5, Shi Z1, Lei X6, Zhang C1, Tan Y1, Chen H1, Guo Z1, Wang L1.

Author information

1Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.2The Mental Health Center of Kunming Medical University, Kunming, China.3Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.4Department of Pathology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.5Department of Gastroenterological Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.6Deparment of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Abstract

Invadopodium formation is a crucial early event of invasion and metastasis of hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying regulation of invadopodia remain elusive. This study aimed to investigate the potential role of discs large homolog 5 (Dlg5) in invadopodium formation and function in HCC. We found that Dlg5 expression was significantly lower in human HCC tissues and cell lines than adjacent nontumor tissues and liver cells. Lower Dlg5 expression was associated with advanced stages of HCC, and poor overall and disease-free survival of HCC patients. Dlg5-silencing promoted epithelial-mesenchymal transition, invadopodium formation, gelatin degradation function, and invadopodium-associated invasion of HepG2 cells. In contrast, Dlg5 overexpression inhibited epithelial-mesenchymal transition, functional invadopodium formation, and invasion of SK-Hep1 cells. Both Girdin and Tks5, but not the Tks5 nonphosphorylatable mutant, were responsible for the enhanced invadopodium formation and invasion of Dlg5-silenced HepG2 cells. Furthermore, Dlg5 interacted with Girdin and interfered with the interaction of Girdin and Tks5. Dlg5 silencing promoted Girdin and Tks5 phosphorylation, which was abrogated by Girdin silencing and rescued by inducing shRNA-resistant Girdin expression. Moreover, Dlg5 overexpression significantly inhibited HCC intrahepatic and lung metastasis in vivo. Taken together, our data indicate that Dlg5 acts as a novel regulator of invadopodium-associated invasion via Girdin and by interfering with the interaction between Girdin and Tks5, which might be important for Tks5 phosphorylation in HCC cells. Conceivably, Dlg5 may act as a new biomarker for prognosis of HCC patients.

KEYWORDS:

CCDC88A protein; Dlg5 protein; SH3PXD2A protein; human hepatocellular carcinoma; invadopodia

0